IMMUNICUM
Immunicum is a clinical phase II company, develops cancer immunotherapies. The Company’s two main groups of therapeutic cancer vaccines, in addition to the method for expansion of tumor-specific T-cells, are based on many years of research within the area of transplantation immunology.
IMMUNICUM
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2002-01-01
Address:
Gothenburg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.immunicum.se
Total Employee:
11+
Status:
Active
Contact:
(463)141-5052
Email Addresses:
[email protected]
Total Funding:
54.6 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Japanese Yen Google Maps For Work Barracuda Networks IP-Only Sweden
Similar Organizations
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.immunicum.se
- Host name: redirect1-1.ilait.se
- IP address: 62.109.34.30
- Location: Sölvesborg Sweden
- Latitude: 56.0521
- Longitude: 14.5753
- Timezone: Europe/Stockholm
- Postal: 294 32
